Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Future of PDSG?

To equate backlog to revenues shows a lack of basic business understanding

Simply put, and to avoid any convoluted debate, the "backlog" this year is far greater than last year. Unless one is trying to suggest that these aren't future revenues, which are increasing?

Would you rather PDSG had a zero backlog?

.

.

.

Be well

Share
New Message
Please login to post a reply